肺癌生存的种族差异:分期、治疗与祖先血统的贡献
研究基于南部社区队列研究(N=425)的黑人和白人非小细胞肺癌病例,评估非洲血统对总生存的影响。结果显示非洲血统与总生存无显著关联,去除分期和治疗后模型预测性能明显下降,提示分期和治疗比非洲血统更能预测生存,种族生存差异或可通过相似的早期检测消除。
要点
- 非洲血统与NSCLC总生存无显著关联
- 分期和治疗是比非洲血统更重要的生存预测因素
- 黑人和白人接受相似早期检测可能消除生存差异
核心结论
- 分期和治疗是比非洲血统更重要的生存预测因素。
- 种族间肺癌生存差异可能通过相似的早期检测努力而消失。
研究设计与样本
- 前瞻性南部社区队列研究(N=425)纳入黑人和白人NSCLC病例。
- 通过州癌症登记处和全国死亡索引确定病例与生命状态。
- 使用全基因组祖先信息标记估计非洲血统,并以Cox比例风险模型计算时间依赖AUC评估总生存。
- 在独立黑人NSCLC病例人群中重复验证。
主要发现
- 全球非洲血统与NSCLC总生存无显著关联。
- 包含与不包含非洲血统的Cox模型性能无变化(AUC=0.79)。
- 去除分期和治疗后,平均时间依赖AUC从0.79降至0.65。
- 重复研究观察到相似结果。
关键数值与推荐
- 含非洲血统与不含非洲血统的Cox模型AUC均为0.79。
- 去除分期和治疗后平均时间依赖AUC从0.79降至0.65。
临床怎么用
- 临床应重视分期和治疗对肺癌生存的预测价值。
- 推动黑人和白人相似的早期检测可能有助于缩小生存差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Lung cancer is a leading cause of cancer-related death worldwide. Racial disparities in lung cancer survival exist between blacks and whites, yet they are limited by categorical definitions of race. We sought to examine the impact of African ancestry on overall survival among blacks and whites with NSCLC cases. METHODS: Incident cases of NSCLC in blacks and whites from the prospective Southern Community Cohort Study (N = 425) were identified through linkage with state cancer registries in 12 southern states. Vital status was determined by linkage with the National Death Index and Social Security Administration. We evaluated the impact of African ancestry (as estimated by using genome-wide ancestry-informative markers) on overall survival by calculating the time-dependent area under the curve (AUC) for Cox proportional hazards models, adjusting for relevant covariates such as stage and treatment. We replicated our findings in an independent population of NSCLC cases in blacks. RESULTS: Global African ancestry was not significantly associated with overall survival among NSCLC cases. There was no change in model performance when Cox proportional hazards models with and without African ancestry were compared (AUC = 0.79 for each model). Removal of stage and treatment reduced the average time-dependent AUC from 0.79 to 0.65. Similar findings were observed in our replication study. CONCLUSIONS: Stage and treatment are more important predictors of survival than African ancestry is. These findings suggest that racial disparities in lung cancer survival may disappear with similar early detection efforts for blacks and whites.
引用
- Jones CC, Mercaldo SF, Blume JD, et al. Racial Disparities in Lung Cancer Survival: The Contribution of Stage, Treatment, and Ancestry. J Thorac Oncol. 2018. PMID: 29885480. doi:10.1016/j.jtho.2018.05.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。